Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Cancer Invest
; 39(1): 9-14, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-894477
ABSTRACT
The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
/
SARS-CoV-2
/
COVID-19
/
Melanoma
Type of study:
Case report
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Cancer Invest
Year:
2021
Document Type:
Article
Affiliation country:
07357907.2020.1844893
Similar
MEDLINE
...
LILACS
LIS